Status:
ACTIVE_NOT_RECRUITING
Effectiveness of Treatments for Cirrhosis With Varicose Veins
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Esophageal Varices Bleeding
Portal Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Liver cirrhosis is the fifth leading cause of death among adults, characterized by diffuse fibrous tissue proliferation and the formation of regenerative nodules and false lobules on the basis of wide...
Eligibility Criteria
Inclusion
- ① Age greater than 18 years, with no gender restriction.
- ② Patients admitted for portal hypertension-related esophageal and gastric varices from February 2022 to December 2024.
Exclusion
- Age \< 18 years ② Absence of esophageal or gastric varices ③ Incomplete medical history records
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
1900 Patients enrolled
Trial Details
Trial ID
NCT06961474
Start Date
February 1 2022
End Date
December 1 2025
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Hospital
Shanghai, Shanghai Municipality, China, 200000